Back to Results
First PageMeta Content
Antiretroviral drug / HIV / Tenofovir / AIDS / Viral load / Zidovudine / Gilead Sciences / Resistance Database Initiative / HIV/AIDS / Medicine / Health


RDI e-News Issue #2 8th September 2003
Add to Reading List

Document Date: 2012-09-28 07:39:30


Open Document

File Size: 521,85 KB

Share Result on Facebook

City

Foster City / Paris / /

Company

Gilead Sciences Inc. / Macmillan Publishers Ltd. / Boehringer Ingelheim / RDI / Actual pre-TCE Actual post-TCE Press / /

Country

United States / Canada / /

/

Facility

University of British Columbia / BC Centre / /

IndustryTerm

database search options / pharmaceutical industry / HIV therapy / /

MedicalCondition

HIV / AIDS / HIV/AIDS / /

MedicalTreatment

antiretroviral therapy / drug therapy / /

Organization

US Federal Reserve / BC Centre / Gilead Sciences Inc. Founding Corporate Supporter BC Centre for Excellence / University of British Columbia / /

Person

Julio Montaner / Andrew Revell / Michael Miller / Brendan Larder / /

Position

CEO / Professor / Chair / scientist / Professor of Medicine and Chair in AIDS Research / Chair of the RDI’s Scientific Core Group / /

ProvinceOrState

British Columbia / California / /

Technology

Neural Network / artificial intelligence / genetic code / genotype / /

URL

Hepatitis.com / www.hivrdi.org / http /

SocialTag